(Q45346807)

13 December 2017

title

Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination (English)

1 reference

13 December 2017

M Krajewska

1

1 reference

13 December 2017

A M Heijink

2

1 reference

13 December 2017

Y J W M Bisselink

3

1 reference

13 December 2017

R I Seinstra

4

1 reference

13 December 2017

H H W Silljé

5

1 reference

13 December 2017

E G E de Vries

6

1 reference

13 December 2017

M A T M van Vugt

7

1 reference

13 December 2017

language of work or name

English

0 references

publication date

16 July 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

32

1 reference

13 December 2017

issue

24

1 reference

13 December 2017

page(s)

3001-3008

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.296

13 December 2017

exact match

0 references

cites work

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

21 January 2018

Cdc2 regulatory factors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

p53 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

CDK targets Sae2 to control DNA-end resection and homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Universal control mechanism regulating onset of M-phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Overall Cdk activity modulates the DNA damage response in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

In my end is my beginning: control of end resection and DSBR pathway 'choice' by cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Cell cycle re-entry mechanisms after DNA damage checkpoints: giving it some gas to shut off the breaks!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

DNA end joining becomes less efficient and more error-prone during cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

XRCC3 promotes homology-directed repair of DNA damage in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

An overview of Cdk1-controlled targets and processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Arrest, adaptation, and recovery following a chromosome double-strand break in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Targets of the cyclin-dependent kinase Cdk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

CDC5 and CKII control adaptation to the yeast DNA damage checkpoint

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.296

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.296

1 reference

Dimensions Publication ID

13 December 2017

1008704118

0 references

1 reference